Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

BACKGROUND: Intravesical chemotherapy and bacillus Calmette-Guérin (BCG) reduce the recurrence rate in patients with stage Ta T1 urothelial bladder cancer; however, the benefit of BCG relative to chemotherapy for long-term end points is controversial, especially in intermediate-risk patients. OBJECT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sylvester, Richard J., Brausi, Maurizio A., Kirkels, Wim J., Hoeltl, Wolfgang, Da Silva, Fernando Calais, Powell, Philip H., Prescott, Stephen, Kirkali, Ziya, van de Beek, Cees, Gorlia, Thierry, de Reijke, Theo M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889174/
https://ncbi.nlm.nih.gov/pubmed/20034729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2009.12.024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi